Research innovation awards

Stage 2 is currently in progress for shortlisted applicants.

Further details can be found in our accompanying Guidance Notes

The deadline for Stage 2 submissions (for shortlisted applicants) is 7 March 2022.


This call is for bold, innovative research that has the real potential to impact the way prostate cancer is diagnosed and treated.

All proposals must align with our research strategy and must clearly demonstrate the innovative nature of the research and how it will lead to the improved health and well-being of men affected by, or at high risk of, prostate cancer. The application and assessment process reflects our increased focus on innovation and potential impact, and so you should make every effort to detail how your proposal meets those criteria.

Remit & Eligibility

We want to see novel, game-changing research! 

As such, there are no financial restrictions as to what you can request – you should simply apply for what you need. However, please note that value for money will be a consideration in making final funding decisions, and so we would advise applicants to ensure that the amount they are requesting is a realistic reflection of what is needed.

We would expect projects to be between 1 to 5 years in duration; however again you should apply for however long you need. Projects that are shorter or longer than 1-5 years are still eligible; although, you should discuss this further with the Research Team at Prostate Cancer UK before applying.

This scheme will fund both fundamental and clinical research (and all stages in between); however, research at all stages will be expected to have a focus on eventual benefit to men. Applicants will be expected to set out a logical and realistic path of work that will need to happen at the end of the award in order to deliver that benefit to men.

We will also consider applications that bring innovative ideas from other cancer types and other diseases to be tested or translated for prostate cancer and we encourage applicants to build teams that include experts from other disciplines and other countries where that will improve the project.

Application & Assessment Process

The application process consists of two stages:

1: Expression of Interest Stage

  • DEADLINE: Call closed at 12pm (noon) on 18 October 2021.
  • SHORTLISTING: Applications were considered by our Research Advisory Committee and a decision made on which proposals to shortlist to the second stage.
  • NOTIFICATION: Applicants were notified of the outcome of their submission in January 2022. Shortlisted applicants were invited to submit a second stage application form.

2: Second Stage (for shortlisted applicants)

  • DEADLINE: Shortlisted applicants must submit their second stage proposals and ensure that all online declarations and approvals have been completed by the relevant parties before 12pm (noon) on 7 March 2022.
  • PEER REVIEW: Submitted applications will then be subject to external peer review (in line with AMRC guidance). The peer reviewers' comments will be sent to the applicants (anonymously) in May 2022 via our online system. Applicants will have an opportunity to submit a response to the reviewers' comments.
  • DECISION: All applications, reviews and rebuttals will then be considered by our Research Advisory Committee who shall make final funding recommendations to our Board of Trustees.
  • NOTIFICATION: Final funding decisions will be in July 2022 and applicants will be notified as to the outcome of their submission via email shortly afterwards. We appreciate your patience during this time.

All awards made will be in line with our terms and conditions (please note - these terms may be subject to change).

Application success rates

  • 2019/20: 17% success rate, 36 Expression of Interest applications received
  • 2018/19: 17% success rate, 48 Expression of Interest applications received
  • 2017/18: 15% success rate, 54 Expression of Interest applications received

Contact Us

If you have any questions or would like to discuss an application with the Research team, please e-mail